Start-Up Raises $200 Million to Speed Up Drug Trials

New York-based Paradigm has raised a significant amount to simplify clinical trials. Its goal is ambitious, but its challenges are many, researchers say.

Maureen Farrell
Author: Maureen Farrell

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *